Samantha Pearce
EVP, Chief Commercial Officer · 4 filings · Latest: May 28, 2026
Jazz Pharmaceuticals plc
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
JAZZ | Samantha Pearce | EVP, Chief Commercial Officer | May 28, 2026 | Sale | $235.41 | 6,907 | $1.6M | 50,272 | |
JAZZ | Samantha Pearce | EVP, Chief Commercial Officer | May 28, 2026 | Option Exercise | $109.45 | 6,907 | $756.0K | 57,179 | |
JAZZ | SAMANTHA PEARCE | — | May 28, 2026 | Proposed Sale | $235.41 | 6,907 | $1.6M | — |